These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Society of Family Planning clinical recommendation: Extended use of long-acting reversible contraception. Dethier D; Qasba N; Kaneshiro B Contraception; 2022 Sep; 113():13-18. PubMed ID: 35716806 [TBL] [Abstract][Full Text] [Related]
5. Canadian Contraception Consensus (Part 2 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725 [TBL] [Abstract][Full Text] [Related]
6. Canadian Contraception Consensus (Part 1 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N; J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712 [TBL] [Abstract][Full Text] [Related]
7. Acceptability of IUDs is increasing. Finger WR; Barr D Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082 [TBL] [Abstract][Full Text] [Related]
8. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic. Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802 [TBL] [Abstract][Full Text] [Related]
9. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S; Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Chi IC Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615 [TBL] [Abstract][Full Text] [Related]
11. Long-acting reversible contraceptives effects in abnormal uterine bleeding, a review of the physiology and management. Castillo K; Zambrano K; Barba D; Robayo P; Sanon S; Caicedo A; Jijon Chiriboga AJ Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():231-238. PubMed ID: 35124300 [TBL] [Abstract][Full Text] [Related]
12. Long-acting reversible contraception: a review in special populations. Prescott GM; Matthews CM Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075 [TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Modesto W; Bahamondes MV; Bahamondes L Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309 [TBL] [Abstract][Full Text] [Related]
14. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement. Bahamondes L; Brache V; Ali M; Habib N; Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663 [TBL] [Abstract][Full Text] [Related]
15. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System. Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847 [No Abstract] [Full Text] [Related]
16. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785 [TBL] [Abstract][Full Text] [Related]
17. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related]
18. Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy. Lotke PS Obstet Gynecol Clin North Am; 2015 Dec; 42(4):557-67. PubMed ID: 26598299 [TBL] [Abstract][Full Text] [Related]
19. How Long-Acting Reversible Contraception Knowledge, Training, and Provider Concerns Predict Referrals and Placement. Thompson CM; Broecker J; Dade M J Am Osteopath Assoc; 2019 Nov; 119(11):725-734. PubMed ID: 31657827 [TBL] [Abstract][Full Text] [Related]
20. Motivational interviewing to promote long-acting reversible contraception among Rwandan couples wishing to prevent or delay pregnancy. Mukamuyango J; Ingabire R; Parker R; Nyombayire J; Easter SR; Wall KM; Tichacek A; Nyirazinyoye L; Kaslow N; Allen S; Karita E Am J Obstet Gynecol; 2020 Apr; 222(4S):S919.e1-S919.e12. PubMed ID: 31838122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]